دورية أكاديمية
Complete Response to Sequential Human Epidermal Growth Factor Receptor 2-Targeted Strategies in a Heavily Pretreated Patient With Human Epidermal Growth Factor Receptor 2-Amplified Metastatic Bladder Cancer.
العنوان: | Complete Response to Sequential Human Epidermal Growth Factor Receptor 2-Targeted Strategies in a Heavily Pretreated Patient With Human Epidermal Growth Factor Receptor 2-Amplified Metastatic Bladder Cancer. |
---|---|
المؤلفون: | Lima NF Jr; Hospital Sírio-Libanês, São Paulo, Brazil., Sampaio LAF; Hospital Sírio-Libanês, São Paulo, Brazil., Xavier CB; Hospital Sírio-Libanês, São Paulo, Brazil., Mattedi RL; Hospital Sírio-Libanês, São Paulo, Brazil., Queiroz MA; Hospital Sírio-Libanês, São Paulo, Brazil., Nahas WC; Hospital Sírio-Libanês, São Paulo, Brazil.; Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil., Jardim DL; Hospital Sírio-Libanês, São Paulo, Brazil.; Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil. |
المصدر: | JCO precision oncology [JCO Precis Oncol] 2023 Jan; Vol. 7, pp. e2200414. |
نوع المنشور: | Case Reports; Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: Alexandria, VA : American Society of Clinical Oncology, [2017]- |
مواضيع طبية MeSH: | Receptor, ErbB-2*/metabolism , Urinary Bladder Neoplasms*/drug therapy , Urinary Bladder Neoplasms*/genetics, Humans |
المشرفين على المادة: | EC 2.7.10.1 (ERBB2 protein, human) EC 2.7.10.1 (Receptor, ErbB-2) |
تواريخ الأحداث: | Date Created: 20230109 Date Completed: 20230112 Latest Revision: 20230223 |
رمز التحديث: | 20231215 |
DOI: | 10.1200/PO.22.00414 |
PMID: | 36623240 |
قاعدة البيانات: | MEDLINE |
تدمد: | 2473-4284 |
---|---|
DOI: | 10.1200/PO.22.00414 |